CNS active O-linked glycopeptides

Frontiers in Chemistry

Volumn 3, Issue JUN, 2015, Pages

  Jones, Evan M ^a   Polt, Robin ^a  

^a University of Arizona   (United States)

Author keywords

Analgesia; Blood brain barrier; CNS; Enkephalin; Glycopeptide; Peptide

Indexed keywords

EID: 84969514592     PISSN: None     EISSN: 22962646     Source Type: Journal    
DOI: 10.3389/fchem.2015.00040     Document Type: Review

References (75)

1. Andersson, L., Stenhagen, G., and Baltzer, L. (1998). The site-selective glycosylation of a designed helix-loop-helix polypeptide motif. J. Org. Chem. 63, 1366-1367. doi: 10.1021/jo971999k
2. Bertozzi, C. R., Hoeprich, P. D., and Bednarski, M. D. (1992). Synthesis of carbon-linked glycopeptides as stable glycopeptide models. J. Org. Chem. 57, 6092-6094. doi: 10.1021/jo00049a005
3. Bilsky, E. J., Egleton, R. D., Mitchell, S. A., Palian, M. M., Davis, P., Huber, J. D., et al. (2000). Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability. J. Med. Chem. 43, 2586-2590. doi: 10.1021/jm000077y
4. Bourgault, S., Chatenet, D., Wurtz, O., Doan, N. D., Leprince, J., Vaudry, H., et al. (2011). Strategies to convert PACAP from a hypophysiotropic neurohormone into a neuroprotective drug. Curr. Pharm. Des. 17, 1002-1024. doi: 10.2174/138161211795589337
5. Broddefalk, J., Nilsson, U., and Kihlberg, J. (1994). An improved synthesis of 3, 4, 6-Tri-O-Acetyl-2-Azido-2-Deoxy-Alpha-D-Galactopyranosyl bromide-a key component for synthesis of glycopeptides and glycolipids. J. Carbohydr. Chem. 13, 129-132. doi: 10.1080/07328309408009183
6. Chakraborty, T. K., Jayaprakash, S., Diwan, P. V., Nagaraj, R., Jampani, S. R. B., and Kunwar, A. C. (1998). Folded conformation in peptides containing furanoid sugar amino acids. J. Am. Chem. Soc. 120, 12962-12963. doi: 10.1021/ja9816685
7. Christie, M. P., Simerska, P., Jen, F. E., Hussein, W. M., Rawi, M. F. M., Hartley-Tassell, L. E., et al. (2014). A drug delivery strategy: binding enkephalin to asialoglycoprotein receptor by enzymatic galactosylation. PLoS ONE 9:e95024. doi: 10.1371/journal.pone.0095024
8. Cohen, M., and Varki, A. (2014). Modulation of glycan recognition by clustered saccharide patches. Int. Rev. Cell Mol. Biol. 308, 75-125. doi: 10.1016/b978-0-12-800097-7.00003-8
9. Craig, A. G., Norberg, T., Griffin, D., Hoeger, C., Akhtar, M., Schmidt, K., et al. (1999). Contulakin-G, an O-glycosylated invertebrate neurotensin. J. Biol. Chem. 274, 13752-13759. doi: 10.1074/jbc.274.20.13752
10. Craig, A. G., Park, M., Fischer, W. H., Kang, J., Compain, P., and Piller, F. (2001). Enzymatic glycosylation of contulakin-G, a glycopeptide isolated from Conus venom, with a mammalian ppGalNAc-transferase. Toxicon 39, 809-815. doi: 10.1016/S0041-0101(00)00211-7
11. D'Souza, S. P., Davis, M., and Baxter, G. F. (2004). Autocrine and paracrine actions of natriuretic peptides in the heart. Pharmacol. Ther. 101, 113-129. doi: 10.1016/j.pharmthera.2003.11.001
12. Dangoor, D., Biondi, B., Gobbo, M., Vachutinski, Y., Fridkin, M., Gozes, I., et al. (2008). Novel glycosylated VIP analogs: synthesis, biological activity, and metabolic stability. J. Pept. Sci. 14, 321-328. doi: 10.1002/psc.932
13. Dhanasekaran, M., and Polt, R. (2005). New prospects for glycopeptide based analgesia: glycoside-induced penetration of the blood-brain barrier. Curr. Drug Deliv. 2, 59-73. doi: 10.2174/1567201052772843
14. Diao, L., and Meibohm, B. (2013). Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptides. Clin. Pharmacokinet. 52, 855-868. doi: 10.1007/s40262-013-0079-0
15. Ding, J. L., Li, P., and Ho, B. (2008). The Sushi peptides: structural characterization and mode of action against Gram-negative bacteria. Cell. Mol. Life Sci. 65, 1202-1219. doi: 10.1007/s00018-008-7456-0
16. Egleton, R. D., Bilsky, E. J., Tollin, G., Dhanasekaran, M., Lowery, J., Alves, I., et al. (2005). Biousian glycopeptides penetrate the blood-brain barrier. Tetrahedron 16, 65-75. doi: 10.1016/j.tetasy.2004.11.038
17. Egleton, R. D., Mitchell, S. A., Huber, J. D., Janders, J., Stropova, D., Polt, R., et al. (2000). Improved bioavailability to the brain of glycosylated Met-enkephalin analogs. Brain Res. 881, 37-46. doi: 10.1016/S0006-8993(00)02794-3
18. Elmagbari, N. O., Egleton, R. D., Palian, M. M., Lowery, J. J., Schmid, W. R., Davis, P., et al. (2004). Antinociceptive structure-activity studies with enkephalin-based opioid glycopeptides. J. Pharmacol. Exp. Ther. 311, 290-297. doi: 10.1124/jpet.104.069393
19. Falenski, J. A., Gerling, U. I. M., and Koksch, B. (2010). Multiple glycosylation of de novo designed alpha-helical coiled coil peptides. Bioorg. Med. Chem. 18, 3703-3706. doi: 10.1016/j.bmc.2010.03.061
20. Fosgerau, K., and Hoffmann, T. (2015). Peptide therapeutics: current status and future directions. Drug Discov. Today 20, 122-128. doi: 10.1016/j.drudis.2014.10.003
21. Gerwig, G. J., Hocking, H. G., Stoecklin, R., Kamerling, J. P., and Boelens, R. (2013). Glycosylation of conotoxins. Mar. Drugs 11, 623-642. doi: 10.3390/md11030623
22. Hennet, T. (2002). The galactosyltransferase family. Cell. Mol. Life Sci. 59, 1081-1095. doi: 10.1007/s00018-002-8489-4
23. Herve, F., Ghinea, N., and Scherrmann, J. (2008). CNS delivery via adsorptive transcytosis. AAPS J. 10, 455-472. doi: 10.1208/s12248-008-9055-2
24. Herzner, H., Reipen, T., Schultz, M., and Kunz, H. (2000). Synthesis of glycopeptides containing carbohydrate and peptide recognition motifs. Chem. Rev. 100, 4495-4537. doi: 10.1021/cr990308c
25. Kaspar, A. A., and Reichert, J. M. (2013). Future directions for peptide therapeutics development. Drug Discov. Today 18, 807-817. doi: 10.1016/j.drudis.2013.05.011
26. Kriss, C. T., Lou, B. S., Szabo, L. Z., Mitchell, S. A., Hruby, V. J., and Polt, R. (2000). Enkephalin-based drug design: conformational analysis of O-linked glycopeptides by NMR and molecular modeling. Tetrahedron 11, 9-25. doi: 10.1016/S0957-4166(99)00544-3
27. Lefever, M. L., Szabo, L. Z., Anglin, B., Ferracane, M., Hogan, J., Cooney, L., et al. (2012). Glycosylation of α-amino acids by sugar acetate donors with InBr3. Minimally competent Lewis acids. Carbohydr. Res. 351, 121-125. doi: 10.1016/j.carres.2012.01.008
28. Li, C., Zhang, Z., Duan, Q., and Li, X. (2014a). Glycopeptide synthesis on an ionic liquid support. Org. Lett. 16, 3008-3011. doi: 10.1021/ol501133u
29. Li, Y., Lefever, M. R., Muthu, D., Bidlack, J. M., Bilsky, E. J., and Polt, R. (2012). Opioid glycopeptide analgesics derived from endogenous enkephalins and endorphins. Future Med. Chem. 4, 205-226. doi: 10.4155/fmc.11.195
30. Li, Y., St Louis, L., Knapp, B. I., Muthu, D., Anglin, B., Giuvelis, D., et al. (2014b). Can amphipathic helices influence the CNS antinociceptive activity of glycopeptides related to beta-endorphin? J. Med. Chem. 57, 2237-2246. doi: 10.1021/jm400879w
31. Lipinski, C. A., Lombardo, F., Dominy, B. W., and Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46, 3-26. doi: 10.1016/S0169-409X(00)00129-0
32. Lotfipour, F., Abdollahi, S., Jelvehgari, M., Valizadeh, H., Hassan, M., and Milani, M. (2014). Study of antimicrobial effects of vancomycin loaded PLGA nanoparticles against enterococcus clinical isolates. Drug Res. 64, 348-352. doi: 10.1055/s-0033-1358747
33. Lowery, J. J., Raymond, T. J., Giuvelis, D., Bidlack, J. M., Polt, R., and Bilsky, E. J. (2011). In vivo characterization of MMP-2200, a mixed delta/mu opioid agonist, in mice. J. Pharmacol. Exp. Ther. 336, 767-778. doi: 10.1124/jpet.110.172866
34. Lowery, J. J., Yeomans, L., Keyari, C. M., Davis, P., Porreca, F., Knapp, B. I., et al. (2007). Glycosylation improves the central effects of DAMGO. Chem. Biol. Drug Des. 69, 41-47. doi: 10.1111/j.1747-0285.2007.00462.x
35. Mabrouk, O. S., Falk, T., Sherman, S. J., Kennedy, R. T., and Polt, R. (2012). CNS penetration of the opioid glycopeptide MMP-2200: a microdialysis study. Neurosci. Lett. 531, 99-103. doi: 10.1016/j.neulet.2012.10.029
36. Meldal, M., and St Hilaire, P. M. (1997). Synthetic methods of glycopeptide assembly, and biological analysis of glycopeptide products. Curr. Opin. Chem. Biol. 1, 552-563. doi: 10.1016/s1367-5931(97)80052-x
37. Merutka, G., and Stellwagen, E. (1990). Positional independence and additivity of amino-acid replacements on helix stability in monomeric peptides. Biochemistry 29, 894-898. doi: 10.1021/bi00456a007
38. Mitchell, S., Pratt, M., Hruby, V., and Polt, R. (2001). Solid-phase synthesis of O-linked glycopeptide analogues of enkephalin. J. Org. Chem. 66, 2327-2342. doi: 10.1021/jo005712m
39. Modi, N. B. (1994). Pharmacokinetics and pharmacodynamics of recombinant proteins and peptides. J. Control. Release 29, 269-281. doi: 10.1016/0168-3659(94)90073-6
40. Mulder, G. J. (1992). Pharmacological effects of drug conjugates-is morphine 6-glucuronide an exception. Trends Pharmacol. Sci. 13, 302-304. doi: 10.1016/0165-6147(92)90095-N
41. Muller, S., and Hanisch, F. G. (2002). Recombinant MUC1 probe authentically reflects cell-specific O-glycosylation profiles of endogenous breast cancer mucin-High density and prevalent core 2-based glycosylation. J. Biol. Chem. 277, 26103-26112. doi: 10.1074/jbc.m202921200
42. Negri, L., Lattanzi, R., Tabacco, F., Orru, L., Severini, C., Scolaro, B., et al. (1999). Dermorphin and deltorphin glycosylated analogues: synthesis and antinociceptive activity after systemic administration. J. Med. Chem. 42, 400-404. doi: 10.1021/jm9810699
43. Negri, L., Lattanzi, R., Tabacco, F., Scolaro, B., and Rocchi, R. (1998). Glycodermorphins: opioid peptides with potent and prolonged analgesic activity and enhanced blood-brain barrier penetration. Br. J. Pharmacol. 124, 1516-1522. doi: 10.1038/sj.bjp.0701971
44. Nomoto, M., Yamada, K., Haga, M., and Hayashi, M. (1998). Improvement of intestinal absorption of peptide drugs by glycosylation: transport of tetrapeptide by the sodium ion-dependent D-glucose transporter. J. Pharm. Sci. 87, 326-332. doi: 10.1021/js970269p
45. Osborne, R., Joel, S., Trew, D., and Slevin, M. (1988). Analgesic activity of morphine-6-glucuronide. Lancet 331, 828-828. doi: 10.1016/S0140-6736(88)91691-1
46. Otvos, L. Jr., Terrasi, M., Cascio, S., Cassone, M., Abbadessa, G., De Pascali, F., et al. (2008). Development of a pharmacologically improved peptide agonist of the leptin receptor. Biochim. Biophys. Acta 1783, 1745-1754. doi: 10.1016/j.bbamcr.2008.05.007
47. Palian, M. M., Boguslavsky, V. I., O'Brien, D. F., and Polt, R. (2003). Glycopeptide-membrane interactions: glycosyl enkephalin analogues adopt turn conformations by NMR and CD in amphipathic media. J. Am. Chem. Soc. 125, 5823-5831. doi: 10.1021/ja0268635
48. Palian, M. M., Jacobsen, N. E., and Polt, R. (2001). O-linked glycopeptides retain helicity in water. J. Pept. Res. 58, 180-189. doi: 10.1034/j.1399-3011.2001.00906.x
49. Parry, A. L., Clemson, N. A., Ellis, J., Bernhard, S. S. R., Davis, B. G., and Cameron, N. R. (2013). 'Multicopy multivalent' glycopolymer-stabilized gold nanoparticles as potential synthetic cancer vaccines. J. Am. Chem. Soc. 135, 9362-9365. doi: 10.1021/ja4046857
50. Pedersen, S. L., Steentoft, C., Vrang, N., and Jensen, K. J. (2010). Glyco-scan: varying glycosylation in the sequence of the peptide hormone PYY3-36 and its effect on receptor selectivity. Chembiochem 11, 366-374. doi: 10.1002/cbic.200900661
51. Penno, M. B., Passaniti, A., Fridman, R., Hart, G. W., Jordan, C., Kumar, S., et al. (1989). In vitro galactosylation of a 110-kDa glycoprotein by an endogenous cell-surface galactosyltransferase correlates with the invasiveness of adrenal carcinoma-cells. Proc. Natl. Acad. Sci. U.S.A. 86, 6057-6061. doi: 10.1073/pnas.86.16.6057
52. Poduslo, J. F., and Curran, G. L. (1994). Glycation increases the permeability of proteins across the blood-nerve and blood-brain barriers. Brain Res. Mol. Brain Res. 23, 157-162. doi: 10.1016/0169-328X(94)90222-4
53. Polt, R., Porreca, F., Szabo, L. Z., Bilsky, E. J., Davis, P., Abbruscato, T. J., et al. (1994). Glycopeptide enkephalin analogs produce analgesia in mice-evidence for penetration of the blood-brain-barrier. Proc. Natl. Acad. Sci. U.S.A. 91, 7114-7118. doi: 10.1073/pnas.91.15.7114
54. Polt, R., Szabo, L., Treiberg, J., Li, Y. S., and Hruby, V. J. (1992). General methods for alpha-O-Ser/thr Or beta-O-Ser/thr glycosides and glycopeptides-solid-phase synthesis of O-glycosyl cyclic enkephalin analogs. J. Am. Chem. Soc. 114, 10249-10258. doi: 10.1021/ja00052a022
55. Prasad, S., Mathur, A., Jaggi, M., Sharma, R., Gupta, N., Reddy, V. R., et al. (2005). Furanoid sugar amino acids as dipeptide mimics in design of analogs of vasoactive intestinal peptide receptor binding inhibitor. J. Pept. Res. 66, 75-84. doi: 10.1111/j.1399-3011.2005.00275.x
56. Purington, L. C., Sobczyk-Kojiro, K., Pogozheva, I. D., Traynor, J. R., and Mosberg, H. I. (2011). Development and in vitro characterization of a novel bifunctional mu-agonist/delta-antagonist opioid tetrapeptide. ACS Chem. Biol. 6, 1375-1381. doi: 10.1021/cb200263q
57. Rao, P. P., and Mohamed, T. (2011). Current and emerging "at-site" pain medications: a review. J. Pain Res. 4, 279-286. doi: 10.2147/JPR.S11308
58. Risseeuw, M., Overhand, M., Fleet, G. W. J., and Simone, M. I. (2013). A compendium of cyclic sugar amino acids and their carbocyclic and heterocyclic nitrogen analogues. Amino Acids 45, 613-689. doi: 10.1007/s00726-013-1521-1
59. Rodriguez, R. E., Rodriguez, F. D., Sacristan, M. P., Torres, J. L., Valencia, G., and Anton, J. M. G. (1989). New glycosyl peptides with high antinociceptive activity. Neurosci. Lett. 101, 89-94. doi: 10.1016/0304-3940(89)90446-1
60. Rudd, P. M., Elliott, T., Cresswell, P., Wilson, I. A., and Dwek, R. A. (2001). Glycosylation and the immune system. Science 291, 2370-2376. doi: 10.1126/science.291.5512.2370
61. Simerska, P., Christie, M. P., Goodwin, D., Jen, F. E., Jennings, M. P., and Toth, I. (2013). Alpha-1, 4-Galactosyltransferase-catalyzed glycosylation of sugar and lipid modified Leu-enkephalins. J. Mol. Catal. B Enzym. 97, 196-202. doi: 10.1016/j.molcatb.2013.08.018
62. Simone, M. I., Soengas, R., Newton, C. R., Watkin, D. J., and Fleet, G. W. J. (2005). Branched tetrahydrofuran a, a-disubstituted-d-sugar amino acid scaffolds from branched sugar lactones: a new family of foldamers? Tetrahedron Lett. 46, 5761-5765. doi: 10.1016/j.tetlet.2005.06.029
63. Storr, S. J., Royle, L., Chapman, C. J., Hamid, U. M. A., Robertson, J. F., Murray, A., et al. (2008). The O-linked glycosylation of secretory/shed MUC1 from an advanced breast cancer patient's serum. Glycobiology 18, 456-462. doi: 10.1093/glycob/cwn022
64. Tavernaro, I., Hartmann, S., Sommer, L., Hausmann, H., Rohner, C., Ruehl, M., et al. (2015). Synthesis of tumor-associated MUC1-glycopeptides and their multivalent presentation by functionalized gold colloids. Org. Biomol. Chem. 13, 81-97. doi: 10.1039/C4OB01339E
65. Taylor, C. M. (1998). Glycopeptides and glycoproteins: focus on the glycosidic linkage. Tetrahedron 54, 11317-11362. doi: 10.1016/S0040-4020(98)00477-3
66. Tosi, G., Fano, R. A., Bondioli, L., Badiali, L., Benassi, R., Rivasi, F., et al. (2011). Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood-brain barrier. Nanomedicine 6, 423-436. doi: 10.2217/nnm.11.11
67. Tosi, G., Vilella, A., Chhabra, R., Schmeisser, M. J., Boeckers, T. M., Ruozi, B., et al. (2014). Insight on the fate of CNS-targeted nanoparticles. Part II: intercellular neuronal cell-to-cell transport. J. Control. Release 177, 96-107. doi: 10.1016/j.jconrel.2014.01.004
68. Waschek, J. A. (2013). VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair. Br. J. Pharmacol. 169, 512-523. doi: 10.1111/bph.12181
69. Werle, M., and Bernkop-Schnurch, A. (2006). Strategies to improve plasma half life time of peptide and protein drugs. Amino Acids 30, 351-367. doi: 10.1007/s00726-005-0289-3
70. Whalen, L. J., and Halcomb, R. L. (2004). Synthesis of an isostere of an O-linked glycopeptide. Org. Lett. 6, 3221-3224. doi: 10.1021/ol0490779
71. Yeomans, L., Muthu, D., Lowery, J., Martinez, H., Abrell, L., Lin, G., et al. (2011). Phosphorylation of enkephalins: NMR and CD studies in aqueous and membrane-mimicking environments. Chem. Biol. Drug Des. 78, 749-756. doi: 10.1111/j.1747-0285.2011.01203.x
72. Yue, X., Falk, T., Zuniga, L. A., Szabo, L., Porreca, F., Polt, R., et al. (2011). Effects of the novel glycopeptide opioid agonist MMP-2200 in preclinical models of Parkinson's disease. Brain Res. 1413, 72-83. doi: 10.1016/j.brainres.2011.07.038
73. Zhang, Y., Muthana, S. M., Barchi, J. J. Jr., and Gildersleeve, J. C. (2012a). Divergent behavior of glycosylated threonine and serine derivatives in solid phase peptide synthesis. Org. Lett. 14, 3958-3961. doi: 10.1021/ol301723e
74. Zhang, Y., Muthana, S. M., Farnsworth, D., Ludek, O., Adams, K., Barchi, J. J. Jr., et al. (2012b). Enhanced epimerization of glycosylated amino acids during solid-phase peptide synthesis. J. Am. Chem. Soc. 134, 6316-6325. doi: 10.1021/ja212188r
75. Zhu, X. M., Pachamuthu, K., and Schmidt, R. R. (2003). Synthesis of S-linked glycopeptides in aqueous solution. J. Org. Chem. 68, 5641-5651. doi: 10.1021/jo034148n